ARQT
Arcutis Biotherapeutics Inc
26.40$
-5.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +1,238.0% | +109.4% | +178.7% | +36.8% | +10.1% | -24.0% | +2.2% | +24.1% | |
| – | +1,238.0% | +108.4% | +175.0% | +37.5% | +8.6% | -24.5% | +1.6% | +22.5% | |
| – | +1,052.5% | +60.8% | +2.8% | +50.6% | -45.3% | +64.8% | -19.3% | -39.9% | |
| – | +1,390.3% | +98.8% | +180.9% | +36.6% | +5.4% | -33.6% | -16.2% | -3.1% | |
| – | – | – | +251.7% | -29.0% | +2,236.5% | +205.1% | +183.1% | +100.1% | |
| – | – | – | – | – | +536.8% | +74.8% | +10.6% | +55.8% | |
| – | – | – | +310.6% | +12.2% | +103.5% | – | – | – | |
| – | – | – | – | – | – | -10.4% | +47.2% | +56.3% | |
| – | +752.1% | -92.6% | +398.2% | +299.6% | +117.0% | +5.4% | -24.3% | +27.3% | |
| – | +286.3% | +95.9% | +331.6% | +47.4% | +13.4% | +23.4% | +73.6% | +60.3% | |
| – | – | – | – | – | +51.7% | +11.9% | +11.6% | +22.0% | |
| – | +235.4% | -22.0% | +408.2% | +3.0% | +20.0% | +35.9% | +18.6% | -11.9% | |
| – | – | – | – | – | +173.4% | +2.0% | -46.9% | +0.7% | |
| – | – | – | +166.7% | +10.0% | -29.6% | -57.7% | +77.7% | +20.3% | |
| – | – | – | – | – | – | – | – | – | |
| – | +3,331.4% | +5.1% | -6.4% | +38.5% | +11.4% | +25.9% | +74.5% | +5.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.